Disclosure Of Interests In Other Entities [Text Block]

Affluent Medical - Filing #2810675

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Disclosure of interests in other entities [text block]	—	—	—	Le périmètre de con	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests	—	—	—	- EUR	—	—	—	—	—	—	—	—	- EUR	—	—	—	—	—
Non-controlling interests	—	—	—	—	- EUR	—	—	—	—	- EUR	—	—	—	—	—	—	—	—
Current assets	—	—	—	—	5 793 EUR	—	—	—	—	7 181 EUR	—	—	—	—	—	—	—	—
Non-current assets	—	—	—	—	50 883 EUR	—	—	—	—	52 839 EUR	—	—	—	—	—	—	—	—
Current liabilities	—	—	—	—	8 418 EUR	—	—	—	—	8 636 EUR	—	—	—	—	—	—	—	—
Non-current liabilities	—	—	—	—	16 733 EUR	—	—	—	—	17 552 EUR	—	—	—	—	—	—	—	—
Revenue	—	—	—	- EUR	—	—	—	—	—	—	—	—	- EUR	—	—	—	—	—
Profit (loss)	15 653 EUR	- EUR	- EUR	15 653 EUR	—	- EUR	- EUR	15 653 EUR	- EUR	—	- EUR	15 227 EUR	15 227 EUR	- EUR	- EUR	15 227 EUR	- EUR	- EUR
Comprehensive income	15 653 EUR	- EUR	- EUR	15 622 EUR	—	- EUR	- EUR	15 622 EUR	31,000 EUR	—	- EUR	15 215 EUR	15 215 EUR	- EUR	12,000 EUR	15 227 EUR	0 EUR	- EUR
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—		—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	- EUR	- EUR	- EUR	31,000 EUR	—	- EUR	- EUR	31,000 EUR	31,000 EUR	—	- EUR	12,000 EUR	12,000 EUR	- EUR	12,000 EUR	- EUR	0 EUR	- EUR
Investments accounted for using equity method	—	—	—	—	- EUR	—	—	—	—	- EUR	—	—	—	—	—	—	—	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	—	—	—	1 658 EUR	—	—	—	—	2 580 EUR	—	—	—	—	—	—	—	—
Depreciation and amortisation expense	—	—	—	2 413 EUR	—	—	—	—	—	—	—	—	2 450 EUR	—	—	—	—	—
Tax expense (income)	—	—	—	150,000 EUR	—	—	—	—	—	—	—	—	173,000 EUR	—	—	—	—	—